Sun Pharmaceutical Industries has informed that the Committee of Directors (Allotment) at its meeting held today i.e. on Tuesday, September 26, 2017 allotted 1,106 equity shares of the Company of Re 1 each, on exercise of stock options under the SUN Employee Stock Option Plan-2015. Accordingly, post the above allotment the paid-up equity share capital of the Company is Rs 2,399,308,086 divided into 2,399,308,086 shares of Re 1 each. The meeting Committee of Directors (Allotment) commenced at 9:30 a.m. and concluded at 9:45 a.m.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: